These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 22945280)
1. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Zhang W; Cong XL; Qin YH; He ZW; He DY; Dai SM Inflammation; 2013 Feb; 36(1):103-9. PubMed ID: 22945280 [TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Dai SM; Nishioka K; Yudoh K Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886 [TBL] [Abstract][Full Text] [Related]
3. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis. Ganesan R; Rasool M Mol Immunol; 2017 Nov; 91():134-144. PubMed ID: 28898718 [TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926 [TBL] [Abstract][Full Text] [Related]
6. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038 [TBL] [Abstract][Full Text] [Related]
7. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
8. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296 [TBL] [Abstract][Full Text] [Related]
9. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6. Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712 [TBL] [Abstract][Full Text] [Related]
10. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864 [TBL] [Abstract][Full Text] [Related]
11. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways. Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479 [TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Hwang SJ; Choi B; Kang SS; Chang JH; Kim YG; Chung YH; Sohn DH; So MW; Lee CK; Robinson WH; Chang EJ Arthritis Res Ther; 2012 Jan; 14(1):R14. PubMed ID: 22264405 [TBL] [Abstract][Full Text] [Related]
15. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis. Cui MY; Li X; Lei YM; Xia LP; Lu J; Shen H Eur Cytokine Netw; 2019 Jun; 30(2):67-73. PubMed ID: 31486401 [TBL] [Abstract][Full Text] [Related]
16. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. Revu S; Neregård P; af Klint E; Korotkova M; Catrina AI Arthritis Res Ther; 2013; 15(6):R205. PubMed ID: 24295447 [TBL] [Abstract][Full Text] [Related]
17. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis. Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535 [TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis. Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis. Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876 [TBL] [Abstract][Full Text] [Related]
20. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]